Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Nasopharyngeal Carcinoma 20Prostatic Neoplasms 7Breast Neoplasms 7Head and Neck Neoplasms 6Esophageal Squamous Cell Carcinoma 6Esophageal Neoplasms 6Rectal Neoplasms 4Radiation Injuries 4Carcinoma, Squamous Cell 4Carcinoma, Non-Small-Cell Lung 4Neoplasm Metastasis 3Nasopharyngeal Neoplasms 3Carcinoma, Hepatocellular 3Uterine Cervical Neoplasms 2Stomach Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Salivary Gland Neoplasms 2Recurrence 2Lung Neoplasms 2Vulvar Neoplasms 1Thyroid Neoplasms 1Sinonasal undifferentiated carcinoma 1Radiation 1Pathologic Complete Response 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Ototoxicity 1Obesity 1Neurotoxicity Syndromes 1Neoplasms 1

Interventions

Thyroidectomy 4Iodine-131 4trametinib 3dabrafenib 3apatinib 3anlotinib 2Surgical Procedures, Operative 2Blood Specimen Collection 2Biopsy, Large-Core Needle 2toripalimab 1tislelizumab 1surufatinib 1regorafenib 1penpulimab 1pembrolizumab 1pazopanib 1palbociclib 1olaparib 1lenvatinib 1famitinib 1camrelizumab 1Ultrasonography 1Thyroxine 1Thyrotropin Alfa 1Sunitinib 1Second Harmonic Generation Microscopy 1Routinely Collected Health Data 1Rosiglitazone 1Robotic Surgical Procedures 1Radiotherapy, Intensity-Modulated 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Thyroid Neoplasms × Radiotherapy, Intensity-Modulated × Clear all
NCT03300765 2017-10-03

Trail Evaluating Apatinib With IMRT for Inoperable or Iodine Refractory Thyroid Cancer

Fudan University

Phase 2 Unknown
20 enrolled
Head & Neck

Thyroid Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡